Plasys300®

Plasys300® is a proprietary botanical ingredient based on cereal pollen, developed to support prostate and urinary health through a science-based approach. It is standardized to ≥50% phytosterols (as β-sitosterol) by GC and ≥1% essential amino acids by HPLC, ensuring consistent composition and reliable batch-to-batch reproducibility. Plasys300® has been investigated for its role in supporting urinary function and helping manage symptoms associated with benign prostatic hyperplasia (BPH), including urinary frequency, urgency, and nocturia. Its mechanism of action is based on a multi-target approach. Phytosterols such as β-sitosterol are associated with pathways linked to prostate health, while essential amino acids contribute to anti-inflammatory activity and urinary comfort. It has also been evaluated in a consumer setting, showing improvements in urinary symptoms and quality of life parameters, including reduced nighttime urination and better sleep quality. With its standardized profile and formulation versatility, Plasys300® enables the development of differentiated solutions in men’s health, particularly in the growing healthy aging category. A cereal pollen-based ingredient designed for brands looking to deliver science-based solutions for prostate and urinary health.